CONTEXT: Hypoxia inducible factor (HIF-1) mediates how cancer cells respond in a microenvironment that lacks normal oxygen concentration. Under normal conditions, HIF-1a is subject to ubiquitination and proteosomal degradation. In response to hypoxia, ubiquitination of HIF-1a decreases dramatically, and the activity of its transcriptional activation domain increases. HIF-1 can act as a transcriptional activator for several glycolic enzymes and key genes, including vascular endothelial growth factor. Target genes contain hypoxia response elements (HRE), including HIF-1 binding sites. By placing green fluorescence protein (GFP) expression under the control of an HRE, it is possible to indirectly detect HIF-1 activity and hypoxia in tissues, according to principal investigator Dr. Zaver Bhujwalla, director of the molecular imaging laboratory at Johns Hopkins University.
RESULTS: At the 2004 ISMRM meeting, Bhujwalla reported that MR, MR spectroscopy, and optical imaging can be used in combination to map vascular volume, permeability, total choline, lactate/lipid levels, and hypoxia. Vascular and metabolic maps of seven tumors were obtained by MR for vascular imaging and MRS for metabolic imaging. Optimal imaging of GFP expression in freshly sectioned tumor tissue was used to visualize hypoxia in relation to the vascular and metabolic maps. Five of seven tumors examined demonstrated colocalization of GFP with high total choline. High permeability was found in and around the GFP and regions of high total choline. Lactate/lipid signal was coincident with some regions of high vascular volume.
IMPLICATIONS: These in vivo data are consistent with cell perfusion studies of the PC-3 cell line under normoxic and hypoxic conditions. The data suggest that hypoxia is a driving factor in the high total choline observed in the tumors, Bhujwalla said.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.